AR and urinary bladder neoplasm: Our in vitro data indicate that androgen/AR signalling is involved in the acquisition of a more aggressive phenotype of bladder tumour cells and that it can be reverted with blockage of AR signalling, advocating the potential benefits of AR‐targeted therapy for UCC.